Management of Pediatric DKA Flashcards
Diabetic ketoacidosis (DKA) can occur in any patient with an absolute or relative insulin deficiency. DKA is defined by the presence of hyperglycemia, ketosis, and acidosis as measured by serum pH or bicarbonate. Outline the lab value cut offs for what is considered “hyperglycemia”, “ketosis”, and “acidosis”. Note: you do not need to distinguish between severity levels of DKA for this question.
Risk factors for DKA include younger age, lower socio-economic status, and delayed diagnosis in new patients. For children and youth with known diabetes, what are some additional risk factors for DKA? Name at least 5 of the 10 listed by the CPS.
i) Previous DKA
ii) Poor glycemic control
iii) Unrecognized insulin pump malfunction
iv) Infection
v) Some medications (e.g., long-acting insulin analogues, atypical antipsychotics, glucocorticoids)
vi) Ethnicity
vii) Limited access to care
viii) Coexisting mental health or social and family issues
ix) Peripubertal stage
x) Adolescence
In DKA, hyperglycemia leads to urinary losses of both water and electrolytes, resulting in volume depletion and metabolic disturbances. Low insulin levels reduce glucose utilization, and subsequent cellular glycopenia triggers increased glucagon release, lipolysis, and oxidation of free fatty acids, with ensuing ketoacidosis. How does the serum potassium level compare to total body potassium in patients with DKA?
Serum potassium may be normal or elevated due to extracellular shifts, but total body potassium is invariably low due to osmotic diuresis and active urinary excretion.
DKA should be differentiated from hyperosmolar hyperglycemic state (HHS). What are some key distinguishing features between DKA and HHS?
HHS is characterized by more severe volume depletion and extreme electrolyte imbalances in the absence of significant ketosis and acidosis.
What are some presenting symptoms of DKA? Note: the initial clinical assessment should include ABCDs and evaluation of tachypnea and altered breathing patterns, perfusion, fluid balance, and level of consciousness. Further evaluation should solicit history of precipitating factors (e.g., infection, intoxication) and medication adherence for individuals with known diabetes.
Polyuria, polydipsia, polyphagia, weakness, nausea, vomiting, abdominal pain, decreased level of consciousness, Kussmaul breathing, and/or acetone breath.
Assessing volume depletion can be difficult, with substantial inter-rater variability. For fluid calculations, it is suggested to use what % values to define volume depletion in cases of mild vs severe DKA?
Mild = a minimum of 5% depletion
More severe DKA = 7-10% depletion
Laboratory evaluation in patients with DKA should include plasma glucose, electrolytes (including calcium, magnesium, and phosphate), urea, creatinine, anion gap, blood gas, osmolality, and serum/urine ketones to determine the severity of DKA. Outline the pH and bicarbonate cut off values for mild vs moderate vs severe DKA severity. Note: The need for additional studies will be based on clinical circumstances (e.g., hemoglobin A1c, evaluation for infection, electrocardiogram if serum potassium is elevated).
A beta-hydroxybutyrate (BHB) level should be measured, if available, in patients with DKA. Do blood BHB levels correlate better with changes in pH and blood bicarbonate than urine ketones? An improved BHB level may indicate that persistent acidosis is due to hyperchloremia.
Yes – urine ketones can be falsely negative.
Cerebral injury (CI) occurs more commonly in children than adults. What are some RF’s for CI in patients with DKA? Name at list 5 of the 10 listed by the CPS. Note: the frequency of clinically significant CI may be as high as 1%, and those individuals experience a morbidity between 21-25% and a mortality between 21-24%.
Clinical CI is more frequent in severe DKA and may be present before treatment is initiated. What are some clinical indicators aka “warning signs” of possible cerebral injury? Name at least 4 of the 9 listed by the CPS.
True or False: Although patients with DKA present with volume depletion, intravenous (IV) fluids have traditionally been restricted in paediatric patients out of concerns for potentiating CI. As an alternative to the traditional osmotic hypothesis of CI, cerebral hypoperfusion and reperfusion likely play a significant role in DKA-related CI. Several levels of evidence, including computed tomography (CT), magnetic resonance imaging (MRI), and cerebral blood flow studies, have shown changes in biochemical markers and progression from cytotoxic to vasogenic edema?
True
Treatment of DKA includes progressive volume expansion and a careful reduction in plasma glucose. The diagnosis of DKA should be confirmed before initiating any interventions. It is important to remember that DKA in children is managed differently than in adults. What are some differences/general principles to consider in paediatric patients specifically?
i) Extra caution when administering IV fluids
ii) Initiating insulin only after IV fluids
iii) Replacing potassium earlier and more aggressively
iv) Avoiding insulin boluses and sodium bicarbonate
What are some general goals for management of patients in DKA? Note: all patients with DKA require careful monitoring and attention to fluid administration, particularly children and youth at higher risk for CI. In paediatric patients without clinical symptoms of CI, no harm has been demonstrated with using more liberal initial fluid resuscitation, with the primary goal of improving tissue perfusion.
i) Correct volume depletion
ii) Correct acidosis
iii) Stop ketogenesis
iv) Correct electrolyte imbalances
v) Restore normal blood glucose
vi) Monitor for and prevent complications (CI, hypoglycemia, symptomatic electrolyte deficiencies, hyperchloremic acidosis)
vii) Manage coexistent illness or precipitating factors
Both saline and balanced crystalloids are appropriate for use as IV fluids in DKA. Balanced crystalloids (e.g., Ringer’s lactate, Plasmalyte) are recognized as safe alternatives to saline for both bolus and ongoing infusions. What are some possible benefits of using balanced crystalloids over saline? Note: while ongoing therapy with 0.45% NaCl with dextrose and added potassium can be safe for most patients with DKA and anormal neurologic status, hypotonic fluids should be avoided in all patients with symptoms of CI.
Balanced crystalloids may minimize hyperchloremic metabolic acidosis, as well as potentially reduce CI and renal injury.
As per the specific fluid recommendations for DKA outlined by the CPS, all DKA patients should receive what minimum fluid bolus, regardless of hemodynamic status? Note: in settings of hypotension or compensated shock, give a fluid bolus within 10-15 minutes and administer additional isotonic fluid rapidly, in 10mL/kg increments to a maximum 40 mL/kg, in consultation with a paediatric intensivist.
10-20mL/kg (to a maximum 1000mL) of isotonic fluid (0.9% NaCl or a balanced crystalloid) over 20-30 minutes.